EP Patent

EP4444345A2 — Herpes simplex virus mrna vaccines

Assigned to ModernaTx Inc · Expires 2024-10-16 · 2y expired

What this patent protects

Provided herein are messenger ribonucleic acid (mRNA) vaccines encoding multiple herpes simplex virus (HSV) antigens involved in viral attachment and entry. Also provided are methods of using the vaccines and compositions comprising the vaccines.

USPTO Abstract

Provided herein are messenger ribonucleic acid (mRNA) vaccines encoding multiple herpes simplex virus (HSV) antigens involved in viral attachment and entry. Also provided are methods of using the vaccines and compositions comprising the vaccines.

Drugs covered by this patent

Patent Metadata

Patent number
EP4444345A2
Jurisdiction
EP
Classification
—
Expires
2024-10-16
Drug substance claim
No
Drug product claim
No
Assignee
ModernaTx Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.